Conversations between the immune and central nervous systems are proving to be essential for the healthy social behavior, learning, and memory.

Once thought only to attack neurons, immune cells turn out to be vital for central nervous system function.

The Scientist’s annual competition uncovered a bonanza of interesting technologies that made their way onto the market and into labs this year.

The body’s own mechanism for dispersing the inflammatory reaction might lead to new treatments for chronic pain.

New evidence points to brain trauma as an environmental risk factor for Alzheimer disease (AD). 

Can mice with humanlike tissues better model drug effects in people?

US salaries are starting to recover after last year’s survey recorded the first-ever drop.

Lyme disease–causing bacteria can outmaneuver antibiotics in vitro and manipulate the mouse immune system.

From a rapid molecular test for COVID-19 to tools that can characterize the antibodies produced in the plasma of patients recovering from the disease, this year’s winners reflect the research community’s shared focus in a challenging year.

The COVID-19 pandemic is still with us. Biomedical innovation has rallied to address that pressing concern while continuing to tackle broader research challenges.